Department of Biotechnology and Bioengineering, Koba Institutional Area, Gandhinagar, Gujarat, India.
MOE&NHC&CAMS Key Laboratory of Medical Molecular Virology, Shanghai Institute of Infections Disease and Biosecurity, & School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai, China.
J Med Virol. 2022 Sep;94(9):4071-4087. doi: 10.1002/jmv.27820. Epub 2022 May 9.
Since the outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, global public health and the economy have suffered unprecedented damage. Based on the increasing related literature, the characteristics and pathogenic mechanisms of the virus, and epidemiological and clinical features of the disease are being rapidly discovered. The spike glycoprotein (S protein), as a key antigen of SARS-CoV-2 for developing vaccines, antibodies, and drug targets, has been shown to play an important role in viral entry, tissue tropism, and pathogenesis. In this review, we summarize the molecular mechanisms of interaction between S protein and host factors, especially receptor-mediated viral modulation of host signaling pathways, and highlight the progression of potential therapeutic targets, prophylactic and therapeutic agents for prevention and treatment of SARS-CoV-2 infection.
自严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 感染引起的 2019 年冠状病毒病 (COVID-19) 爆发以来,全球公共卫生和经济遭受了前所未有的破坏。基于不断增加的相关文献、病毒的特征和发病机制,以及疾病的流行病学和临床特征正在被迅速发现。刺突糖蛋白(S 蛋白)作为开发疫苗、抗体和药物靶点的 SARS-CoV-2 的关键抗原,已被证明在病毒进入、组织嗜性和发病机制中发挥重要作用。在这篇综述中,我们总结了 S 蛋白与宿主因子相互作用的分子机制,特别是受体介导的病毒对宿主信号通路的调节,并强调了潜在治疗靶点的进展、预防和治疗 SARS-CoV-2 感染的预防性和治疗性药物。